Science Sun Pharm
3004858.803.29% ( +0.28 )
Science Sun Pharm (300485)
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. Th...
- Open
- 8.53
- High
- 8.82
- Low
- 8.52
- Prev. Close
- 8.52
- Volume
- 66.50K
- Turnover
- 58.11M
- Avg Price
- 8.74
- Bid/Ask Ratio
- --
- Amplitude
- 3.52%
- 52wk High
- 16.22
- Volume Ratio
- 0.37
- Turnover Ratio
- 1.38%
News
- Zhitong · Oct 23, 2025 at 07:23 AM
Science Sun Pharm: Net profit in the third quarter was 4.0733 million yuan, a decrease of 41.41%
- Zhitong · Sep 19, 2025 at 06:57 AM
Science Sun Pharm shareholders Ma Li and Liu Shuqin plan to collectively reduce their holdings by no more than 2%
- Zhitong · Aug 21, 2025 at 03:19 AM
Science Sun Pharm: In the first half of 2025, net profit was 47.7862 million yuan, a year-on-year increase of 145.45%
- Wallstreetcn · Jul 25, 2025 at 02:54 AM
China Science Sun Pharm is in talks to authorize weight loss drugs in the United States. (Reuters)
- Zhitong · Jul 7, 2025 at 08:36 PM
The monoclonal antibody concept was active at the beginning of the trading session, with Science Sun Pharm and HAINAN HAIYAO both rising over 9%, while YILING PHARMACEUTICAL, Zhongyuan Union, and FUDANZHANGJIANG also saw gains
- Zhitong · Jul 2, 2025 at 08:42 PM
Innovative drug concept stocks are repeatedly active, Thalys has three consecutive limit-ups
